Stockscreener 앱 받기
10.53
0.47%
-0.05
Anika Therapeutics Inc 주식(ANIK)의 최신 뉴스
Comparing Vivos (OTCMKTS:RDGL) & Anika Therapeutics (NASDAQ:ANIK) - Defense World
Two Sigma Investments LP Cuts Stock Holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Bank of America Corp DE Boosts Stake in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Millennium Management LLC Sells 14,006 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Squarepoint Ops LLC Invests $212,000 in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Acquired by Wellington Management Group LLP - Defense World
Mackenzie Financial Corp Invests $231,000 in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Public Employees Retirement System of Ohio Invests $137,000 in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ANIK Stock News - GuruFocus
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Latest: Orthopedics Leader Anika Therapeutics Issues New Employee Stock Options Worth $28,625 - Stock Titan
Kalkine Biggest NASDAQ Companies Including Anika Therapeutics in Biotechnology Sector - Kalkine Media
Two Sigma Advisers LP Sells 12,800 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Ameriprise Financial Inc. Boosts Holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Long Term Trading Analysis for (ANIK) - news.stocktradersdaily.com
Jane Street Group LLC Acquires 3,065 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
BNP Paribas Financial Markets Increases Holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Deutsche Bank AG Lowers Stock Position in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Orthopedic Regenerative Medicine Market Is Booming Worldwide | - openPR.com
Anika Therapeutics focuses on Hyalofast and Cingal advancements for 2025 growth - MSN
Anika Therapeutics (ANIK) Sees Target Price Adjustment Amid Futu - GuruFocus
Tower Research Capital LLC TRC Acquires 2,326 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika Therapeutics (NASDAQ:ANIK) Downgraded by StockNews.com to “Hold” - Defense World
Anika Therapeutics (ANIK) Stock Maintains "Outperform" Rating De - GuruFocus
Viscosupplementation Market: Executive Briefing & Strategic - openPR.com
Company News for May 12, 2025 - Zacks Investment Research
Anika Therapeutics (ANIK) Reports Q1 Loss, Misses Revenue Estimates - MSN
Wells Fargo & Company MN Boosts Stock Position in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Investor Network: Anika Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2025 Earnings Call Transcript - Insider Monkey
Anika Therapeutics First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Revenues Working Against Anika Therapeutics, Inc.'s (NASDAQ:ANIK) Share Price - simplywall.st
Anika Therapeutics (ANIK) Faces OEM Challenges Amid Commercial G - GuruFocus
Dimensional Fund Advisors LP Sells 50,011 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika: Q1 Earnings Snapshot - News-Times
Anika Reports First Quarter 2025 Financial Results - GlobeNewswire
Anika Therapeutics Inc (ANIK) Q1 2025 Earnings Call Highlights: Strategic Growth Amidst Revenue ... - Yahoo Finance
Anika Therapeutics Inc (ANIK) Q1 2025 Earnings Call Highlights: Strategic Growth Amidst Revenue Challenges - GuruFocus
Earnings call transcript: Anika Therapeutics Q1 2025 misses forecasts, shares fall - Investing.com Nigeria
Anika Therapeutics Reports Mixed Q1 2025 Results - TipRanks
Anika Therapeutics’ Mixed Earnings Call Reveals Challenges and Growth - TipRanks
Anika Therapeutics Inc Reports Q1 2025 Earnings: EPS of -$0.28 M - GuruFocus
Anika Therapeutics (ANIK) Faces OEM Challenges Amid Commercial Growth - GuruFocus
Anika Therapeutics (ANIK) Reports Revenue Miss, Highlights Strat - GuruFocus
Anika Therapeutics Inc Reports Q1 2025 Earnings: EPS of -$0.28 Misses Estimate, Revenue of $26.2M Below Expectations - GuruFocus
Anika Therapeutics Posts Wider Loss From Cont. Ops. In Q1 - Nasdaq
Anika (ANIK) Revises 2025 Revenue and Adjusted EBITDA Outlook | ANIK Stock News - GuruFocus
Anika Therapeutics Reports 18% Growth in Commercial Channel Revenue for Q1 2025 Despite Overall Revenue Decline - Nasdaq
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2024 Earnings Call Transcript - MSN
Barclays PLC Buys 2,093 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Earnings To Watch: Anika Therapeutics Inc (ANIK) Reports Q1 2025 Result - GuruFocus
1.05%
0.60%
자본화:
|
볼륨(24시간):